Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosa
The primary objective of this study is to assess the effect of enobosarm on total body weight
| Condition(s) | Obesity & Overweight, Mobility Disability, HOMA-IR |
|---|---|
| Status | Recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Summary | The primary objective of this study is to assess the effect of enobosarm on total body weight |
| Who can participate | Inclusion Criteria: * Subjects accepted for this study must: 1. Provide informed consent from the subject or the subject's legally authorized representative 2. Be able to communicate effectively with the study personnel 3. Be ≥65 years of age at the time of screening 4. For Female Subjects Menopausal status Be postmenopausal as defined by either: * one year or more of amenorrhea * surgical menopause with bilateral oophorectomy * Be premenopausal or perimenopausal with a negative pregnancy test. * If subject is of child bearing potential, the subject must agree to use acceptable methods of contraception: If female study participant could become pregnant, use acceptable methods of contraception from the time of the first administration of study medication until 30 days following administrati |
| Ages | 65 Years to 100 Years |
| Sex | All |
| Lead sponsor | Veru Inc. |
| Locations | Phoenix, Arizona, United States; Doral, Florida, United States; Doral, Florida, United States; Miami, Florida, United States; Miami, Florida, United States; Miami, Florida, United States (+4 more sites) |
| Start date | 2026-03-26 |
| NCT ID | NCT07446998 |
| Official listing | https://clinicaltrials.gov/study/NCT07446998 |